2 Top Biotech Stocks to Buy in May
Mounting uncertainty over the potential for a global recession led the S&P 500 index to fall into a bear market on May 20. But not all stocks have fared poorly.
Pharma stocks Merck (NYSE: MRK) and Johnson & Johnson (NYSE: JNJ) have gained 23% and 5%, respectively, year to date. And based on their valuations, the two stocks look like solid long-term buys right now.
Merck's $233 billion market capitalization positions it as the fifth-largest pharma stock in the world. The company has an excellent drug portfolio and pipeline that should bode well for the future.
Source Fool.com
